Wellbeing startup Psychological Technologies (PSYT) has raised over £1.7m, supported by Angel Investment Network, the world’s largest online angel investment platform. The startup turns the advice of the world's leading self-development authors into digital, action-based summaries to help individuals create real change.  Founded by the former Head of Research at Headspace Nick Begley, PSYT launched an MVP last year based on a single book called “The Anxiety Solution” to test the proposition. The MVP was featured by Apple in the “Best Apps of March 2020” and has an average rating of 4.9*. The raise took eight weeks with the funding being used to bulk out the full-time team, develop more content and launch a multibook platform.

Drug discovery and development company, Blueberry Therapeutics, is announcing a £3.6m extension to its previously successful £10.8m Series B fundraising.

Japanese investor, Medical Incubator Japan (MIJ), and a private syndicate of US Board Certified Dermatologists - led by Dr Omar Ibrahimi of the Connecticut Skin Institute - have invested £3.1m and £500k, respectively.

BGF has exitedf its investment in Arcinova, the U.K.-based multiservice contract development and manufacturing organization (CDMO). Following a period of growth and expansion, the business has been acquired by Quotient Sciences, the drug development and manufacturing accelerator, backed by the global private equity firm Permira.

Pembroke VCT, the venture capital trust focused on building the brands of tomorrow, has made an initial investment of £1 million into Credentially, the platform that automates healthcare hiring, onboarding and compliance. During the pandemic, the company has worked with the NHS to speed up the registration of healthcare professionals.

Credentially was launched in 2016 by founders Kit Latham, a former A&E doctor and Artem Stalpouski, a software engineer. They combined their experience and expertise to address the lengthy hiring processes, disjointed onboarding efforts and fragmented compliance reporting that healthcare providers currently experience.

BGF, the UK’s most active investor in growth economy businesses, has successfully exited its investment in Renal Services, an independent provider of dialysis services, after it was acquired by DaVita UK Limited, a DaVita International Group Company.

London-based Vamstar, which is creating the world's first AI powered B2B healthcare marketplace, has completed a $1.7 million seed funding led by btov with participation from Antler and Begin Capital.

The Imperial College Innovation Fund (ICIF), an early-stage investment fund launched at Imperial in early 2020 and managed by Parkwalk Advisors to invest in early-stage, high-growth, knowledge-intensive companies, has completed its first investment of £205,000 into Charco Neurotech. 

The team of designers, doctors, engineers and scientists at Charco Neurotech are developing a non-invasive vibrating device called CUE1 to help manage Parkinson’s symptoms. The investment from ICIF is part of a £500,000 seed round from investors, including Amadeus Capital Partners, Crista Galli, RCA and Oxbridge Angels. The investment will be used to launch CUE 1 in the UK/EU market in early 2021. 

Pembroke VCT, the venture capital trust focused on building the brands of tomorrow, has made an initial investment of £1 million into Credentially, the platform that automates healthcare hiring, onboarding and compliance. During the pandemic, the company has worked with the NHS to speed up the registration of healthcare professionals.

Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through psychedelic medicine, has received Clinical Trial Authorisation (CTA) from the UK Medicine and Healthcare Products Regulatory Agency (MHRA) to explore the effects of psychedelic agent psilocybin for treating short-lasting unilateral neuralgiform headache attacks (SUNHA), a rare and debilitating headache condition.

A Warwickshire-based manufacturer of fertility monitoring products, Fertility Focus, has secured further investment from MEIF through a £250,000 loan, enabling it to invest in its staff, continue research and development, while safeguarding against the impact of COVID-19.

A group of successful Bristol-based entrepreneurs has invested £192,500 into a research and development project in the city that is searching for faster diagnosis and treatment of Sepsis, which is the number one cause of death worldwide.  Sixteen members of Bristol Private Equity Club have backed GenomeKey, which is carrying out the pioneering research programme in Bristol. The investment will enable GenomeKey to leverage additional grant funding.

Birmingham-based tele-optometry manufacturer Eyoto,has secured funding from the Midlands Engine Investment Fund (MEIF) WM Equity Finance Fund, managed by venture capital firm Midven as part of a £2.5M funding round. Other investors in the round included Mercia Asset Management, the Future Fund and a group of angel investors.